24 results
8-K
EX-10.1
GOSS
Gossamer Bio Inc
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
conditions of approval and policies imposed by any institutional review board, ethics review board or committee responsible for the oversight
PRE 14A
GOSS
Gossamer Bio Inc
17 Apr 23
Preliminary proxy
4:01pm
;
reviewing and approving any related party transactions and reviewing and monitoring compliance with our code of conduct and ethics; and
reviewing … , appointing) such candidates, will take into account many factors, including the following:
personal and professional integrity, ethics and values
424B5
bib p4ndukjh50
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
vjqp798y813ui97wbt
19 May 20
Prospectus supplement for primary offering
5:08pm
424B5
hdvv2i8ur3lwvx
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
qfs4mq7jyfy5d0m
18 May 20
Prospectus supplement for primary offering
4:11pm
DEF 14A
zf57gus5lstwb en546
30 Apr 19
Definitive proxy
4:04pm
10-K
7i381 f6x4q
22 Mar 19
Annual report
4:45pm
424B4
dzu3wk3o8tg8ioe
8 Feb 19
Prospectus supplement with pricing info
4:40pm